Verification evidence is still being completed.
PDF / print export
Camurus
Lund, Sweden
- Verified lead
- Fredrik Tiberg
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- President and Chief Executive Officer
- 2026 technical specialization
- Long-Acting Drug Delivery and Specialty Pharmaceutical Development
- Review cycle
- May 2026
- Full address
- Rydbergs torg 4, 224 84 Lund, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Camurus management team page confirming Fredrik Tiberg as CEO.
- Editorial note
- Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile.
Long-Acting Drug Delivery and Specialty Pharmaceutical Development
Clinical and commercial pharmaceutical quality systems, Specialty pharma operating controls
Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
Company profile · Lund, Sweden
Camurus
Long-Acting Drug Delivery and Specialty Pharmaceutical Development · Late-stage and commercial specialty pharma
Verified 14 Mar 2026 · 3 sources
Commercial
Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile.
Contact & location
- Website
- camurus.com
- Company page
- Lead
- Fredrik Tiberg (verified ↗)
- Compliance
- GLP
- Last reviewed
- 14 Mar 2026 (4mo ago)
- Scale
- Late-stage and commercial specialty pharma
- Capabilities
- Long-Acting Drug Delivery · Specialty Pharma Development · Commercial Product Operations
- Founded
- 1991
- Headcount
- 51-200
Long-Acting Drug Delivery and Specialty Pharmaceutical Development
Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile.
Editorial note
Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Fredrik Tiberg
President and Chief Executive Officer
Full addressRydbergs torg 4, 224 84 Lund, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Camurus press release and footer contact naming Camurus AB at Rydbergs torg 4 in Lund.
Open sourceLate-stage and commercial specialty pharma
Lund, Sweden. Long-Acting Drug Delivery and Specialty Pharmaceutical Development. Review completed on 14 Mar 2026.
Swedish and EU pharmaceutical oversight
Clinical and commercial pharmaceutical quality systems, Specialty pharma operating controls
Capabilities
Long-Acting Drug Delivery
Specialty Pharma Development
Commercial Product Operations
Sources
The official sources used to verify this profile.
Infrastructure
Formulation laboratories
Development analytics
Commercial operations systems
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- VERIFIED ACTIVE 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
Frequently asked questions
- Where is Camurus located?
- Camurus operates from Rydbergs torg 4, 224 84 Lund, Sweden, Lund, Sweden.
- Who runs Camurus?
- Camurus is led by Fredrik Tiberg, President and Chief Executive Officer. Verified 14 Mar 2026.
- What does Camurus do?
- Camurus joins the Swedish directory layer with a current official executive disclosure and a clearly defined specialty-pharma operating profile. Core capabilities: Long-Acting Drug Delivery, Specialty Pharma Development, Commercial Product Operations.
Editorial context
Related technical briefs
Briefs that name Lund as a covered market or city.